Berti, Alvise
 Distribuzione geografica
Continente #
NA - Nord America 3.524
AS - Asia 3.474
EU - Europa 1.974
SA - Sud America 743
Continente sconosciuto - Info sul continente non disponibili 390
AF - Africa 93
OC - Oceania 20
Totale 10.218
Nazione #
US - Stati Uniti d'America 3.385
SG - Singapore 1.226
IT - Italia 842
CN - Cina 656
VN - Vietnam 599
BR - Brasile 580
RU - Federazione Russa 239
HK - Hong Kong 237
BD - Bangladesh 191
FR - Francia 143
KR - Corea 131
GB - Regno Unito 130
DE - Germania 119
LV - Lettonia 119
IN - India 113
FI - Finlandia 108
NL - Olanda 87
ID - Indonesia 80
CA - Canada 70
AR - Argentina 59
EC - Ecuador 45
JP - Giappone 39
MX - Messico 39
ES - Italia 34
AT - Austria 33
SE - Svezia 26
ZA - Sudafrica 26
IQ - Iraq 24
CO - Colombia 23
TR - Turchia 23
UA - Ucraina 18
AU - Australia 17
MA - Marocco 17
PL - Polonia 17
IR - Iran 16
SA - Arabia Saudita 16
PK - Pakistan 15
TW - Taiwan 13
EG - Egitto 12
IE - Irlanda 12
MY - Malesia 12
PH - Filippine 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
CL - Cile 9
TN - Tunisia 9
PS - Palestinian Territory 8
AZ - Azerbaigian 7
DZ - Algeria 7
KE - Kenya 7
PY - Paraguay 7
JO - Giordania 6
NP - Nepal 6
TH - Thailandia 6
UZ - Uzbekistan 6
BE - Belgio 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
JM - Giamaica 5
KZ - Kazakistan 5
LT - Lituania 5
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
LB - Libano 4
PE - Perù 4
TT - Trinidad e Tobago 4
LK - Sri Lanka 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
QA - Qatar 3
AD - Andorra 2
AL - Albania 2
BB - Barbados 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
MD - Moldavia 2
OM - Oman 2
SN - Senegal 2
SV - El Salvador 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
CD - Congo 1
CU - Cuba 1
DJ - Gibuti 1
DK - Danimarca 1
GH - Ghana 1
GR - Grecia 1
KW - Kuwait 1
MC - Monaco 1
Totale 9.821
Città #
Singapore 803
Ashburn 536
San Jose 517
Santa Clara 309
Columbus 308
Trento 263
Dallas 244
Hong Kong 213
Ho Chi Minh City 182
Council Bluffs 170
New York 137
Hanoi 130
Moscow 126
Seoul 125
Riga 119
Los Angeles 114
Milan 109
Hefei 103
Lauterbourg 100
Beijing 86
Helsinki 72
Buffalo 60
Rome 60
The Dalles 54
São Paulo 48
Redondo Beach 39
Boardman 36
Jakarta 36
Chicago 33
Da Nang 32
Orem 32
Rio de Janeiro 30
Haiphong 27
Lappeenranta 26
Washington 26
Tokyo 25
Munich 22
Nuremberg 22
London 21
Montreal 21
Can Tho 20
Stockholm 20
Frankfurt am Main 19
Toronto 19
Chennai 18
Manchester 18
Mexico City 18
Naples 18
Shanghai 17
Miano 16
Quito 16
San Francisco 16
Biên Hòa 15
Bắc Ninh 15
Castello Molina di Fiemme 15
Groningen 15
Guangzhou 15
Gurugram 15
Hyderabad 15
Vienna 15
Warsaw 15
Brooklyn 14
Amsterdam 13
Guayaquil 13
Hải Dương 13
Johannesburg 13
Atlanta 12
Boston 12
Ogden 12
Thái Bình 12
Turin 12
Bologna 11
Falkenstein 11
Kilburn 11
Paris 11
Poplar 11
Tampa 11
Baghdad 10
Denver 10
Mumbai 10
Pamplona 10
Salt Lake City 10
Turku 10
Wilmington 10
Belo Horizonte 9
Brasília 9
Dublin 9
Houston 9
Istanbul 9
Ninh Bình 9
Phoenix 9
Porto Alegre 9
Salvador 9
Cape Town 8
Palermo 8
Ramallah 8
St Louis 8
Baku 7
Bogotá 7
Buenos Aires 7
Totale 6.162
Nome #
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update 207
Autoreactive B Cells in ANCA-Associated Vasculitis 202
Small airway dysfunction and impulse oscillometry in adult patients with asthma: recent findings 181
Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study 175
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow 168
Severe asthma: One disease and multiple definitions 151
Aging in Granulomatosis with Polyangiitis and Microscopic Polyangiitis: From Pathophysiology to Clinical Management 142
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study 141
Impulse oscillometry for the evaluation and management of pediatric asthma 139
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 138
A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis 134
Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations 133
Small airway dysfunction mediates the relationship between Fractional Exhaled Nitric Oxide and asthma control 124
Outer membrane vesicles from the gut microbiome contribute to tumor immunity by eliciting cross-reactive T cells 123
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis 121
Small airway dysfunction and obesity in asthmatic patients: a dangerous liaison? 117
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 113
Identification and phenotyping of circulating autoreactive proteinase 3-specific B cells in patients with PR3-ANCA associated vasculitis and healthy controls 109
Interleukin-6 in ANCA-associated Vasculitis: Rationale for Successful Treatment With Tocilizumab 105
The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions 105
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan 104
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 103
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study 102
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 101
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles 101
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis 100
Disease and Treatment-Related Morbidity in Young and Elderly Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis 99
Clinical Characterization and Predictors of IOS-Defined Small-Airway Dysfunction in Asthma. 98
Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determines disease severity and long-term outcomes 98
Advances in the pharmacotherapeutic management of eosinophilic granulomatosis with polyangiitis 97
Oscillometry-defined small airways dysfunction as a treatable trait in asthma 94
Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case series 94
Asthma and COVID-19: a dangerous liaison? 93
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease 92
Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management 91
Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. 91
Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysis 90
Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab 89
Efficacy of rituximab and plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis with severe kidney disease 87
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 87
Aortic thrombosis secondary to clopidogrel-related thrombotic thrombocytopenic purpura 87
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells 87
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 86
Diagnosing and treating ANCA-Associated vasculitis: An updated review for clinical practice 86
Practical approach to vasculitides in adults: an overview of clinical conditions that can mimic vasculitides closely 86
Kaposi's Sarcoma in a Patient With Eosinophilic Granulomatosis With Polyangiitis While Taking Mycophenolate Mofetil 86
Allergic rhinitis and COVID-19: friends or foes? 84
Efficacy and safety of biological agents in adult-onset Still's disease 83
Association of Smoking and Obesity on the Risk of Developing Primary Sjögren Syndrome: A Population-based Cohort Study 83
Authors' response 81
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 80
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 80
Remission maintenance in ANCA-associated vasculitis: does one size fit all? 79
Health Literacy and Outcomes Among Patients With Heart Failure: A Systematic Review and Meta-Analysis 79
Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study 77
Eosinophilic Granulomatosis With Polyangiitis: Clinical Predictors of Long-term Asthma Severity 77
Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort 76
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 76
Characterizing the preserved ratio impaired spirometry phenotype in all severities of asthma 76
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis 75
A second case of pericardial mesothelioma mimicking systemic lupus erythematosus in the literature in over 30 years: a case report 75
Prevalence and features of IOS-defined small airway disease across asthma severities 75
Erdheim-Chester disease 74
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study 73
Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis 73
Eosinophilic granulomatosis with polyangiitis: the multifaceted spectrum of clinical manifestations at different stages of the disease 72
Small Airways: The “Silent Zone” of 2021 GINA Report? 72
Immune and cellular damage biomarkers to predict COVID-19 mortality in hospitalized patients 72
Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature 72
Severe/uncontrolled Asthma and Overall Survival in Atopic Patients With Eosinophilic Granulomatosis With Polyangiitis 71
Tocilizumab in patients with multisystem Erdheim-Chester disease 70
Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis 70
Clinical picture, outcomes, and predictors of relapse in eosinophilia-associated coronary vasospasm: Data from a European multicentric study 70
Correction to: Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan (Drugs, (2024), 84, 6, (661-684), 10.1007/s40265-024-02037-0) 70
Giant cell arteritis restricted to the limb arteries: An overlooked clinical entity 69
Cardiovascular manifestations of Erdheim-Chester disease 68
Disease trends over time and CD4 + CCR5 + T-cells expansion predict carotid atherosclerosis development in patients with systemic lupus erythematosus 68
Small-airway dysfunction in paediatric asthma 68
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease. 68
Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer 67
Chronic Rhinosinusitis in Eosinophilic Granulomatosis With Polyangiitis: Clinical Presentation and Antineutrophil Cytoplasmic Antibodies 66
Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests 66
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 64
Psychometric properties of outcome measurement instruments for ANCA-associated vasculitis: A systematic literature review 64
Drug induced exfoliative dermatitis: state of the art. 63
Hypertrophic Cardiomyopathy Secondary to Hepatitis C Virus-Related Vasculitis 62
Dupilumab reduces patient-reported cough and improves quality of life in patients with severe eosinophilic asthma with or without chronic rhinosinusitis with nasal polyps: a real-life prospective study 62
Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma 62
Assessment Of Tocilizumab In The Treatment Of Cancer Cachexia 62
Histamine release positive test associates with disease remission in chronic spontaneous urticaria: a proof-of-concept study 61
BRAFV600E-mutation Is Invariably Present and Associated to Oncogene-Induced Senescence in Erdheim-Chester Disease 61
The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis 60
Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review 59
Proposal of a skin tests based approach for the prevention of recurrent hypersensitivity reactions to iodinated contrast media 59
Juxta-vertebral lesions in granulomatosis with polyangiitis 59
Predicting Disease Activity in Systemic Vasculitides: On the Hunt for Potential Candidates 59
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 58
Update on the epidemiology, risk factors, and outcomes of systemic vasculitides 57
Obesity is a Major Risk Factor for Hospitalization in Community-Managed COVID-19 Pneumonia 57
Targeting the interleukin-5 pathway in EGPA: Evidence, uncertainties and opportunities 56
Totale 8.997
Categoria #
all - tutte 45.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 154
Totale 45.237


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202237 0 0 0 2 9 3 2 7 2 5 3 4
2022/2023328 4 0 0 1 0 0 0 0 0 123 107 93
2023/2024322 1 1 32 13 53 83 27 12 3 27 19 51
2024/20252.850 64 22 307 499 157 303 37 97 221 298 245 600
2025/20266.020 282 201 705 1.036 570 324 1.013 145 513 460 343 428
2026/2027661 299 362 0 0 0 0 0 0 0 0 0 0
Totale 10.218